Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 14,812 | 826 | 1,427 | 2,359 |
| Gross Profit | 14,812 | 826 | 1,427 | 2,359 |
| Operating Expenses | 31,672 | 18,590 | 20,086 | 21,890 |
| Operating Income | -16,860 | -17,764 | -18,659 | -19,531 |
| Other Income | 889 | 412 | 621 | 1,119 |
| Pre-tax Income | -15,971 | -17,352 | -18,038 | -18,412 |
| Net Income Continuous | -15,971 | -17,352 | -18,038 | -18,412 |
| Net Income | $-15,971 | $-17,352 | $-18,038 | $-18,412 |
| EPS Basic Total Ops | -7.50 | -100.40 | -106.50 | -122.90 |
| EPS Basic Continuous Ops | -7.54 | -96.88 | -106.48 | -122.91 |
| EPS Diluted Total Ops | -7.50 | -100.40 | -106.50 | -122.90 |
| EPS Diluted Continuous Ops | -7.54 | -96.88 | -106.48 | -122.91 |
| EBITDA(a) | $-15,963 | $-16,607 | $-17,652 | $-18,895 |